These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11817124)

  • 1. [Acquired factor V inhibitor: etiology, bleeding risk and therapeutic management with regard to three cases].
    Schleinitz N; Veit V; Chouquet D; Seux V; Arnoux D; Mokart D; Lelong B; Alessi MC; Kaplanski G; Harlé JR
    Rev Med Interne; 2001 Nov; 22(11):1119-23. PubMed ID: 11817124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases.
    Spero JA
    J Neurosurg; 1993 May; 78(5):817-20. PubMed ID: 8468613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
    Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
    Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
    Smid WM; de Wolf JT; Nijland JH; Bom VJ; van der Meer J
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):133-7. PubMed ID: 8180333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor V inhibitor. A problem-based systematic review.
    Ang AL; Kuperan P; Ng CH; Ng HJ
    Thromb Haemost; 2009 May; 101(5):852-9. PubMed ID: 19404538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child.
    Muntean W; Zenz W; Finding K; Zobel G; Beitzke A
    Acta Paediatr; 1994 Jan; 83(1):84-7. PubMed ID: 8193480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
    Motwani P; Howard L; Ali SS
    Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
    Zehnder JL; Leung LL
    Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
    Tarantino MD; Ross MP; Daniels TM; Nichols WL
    J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy of an acquired factor V inhibitor.
    Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
    Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product.
    Kajitani M; Ozdemir A; Aguinaga M; Jazieh AR; Flick JT; Antakli T
    J Card Surg; 2000; 15(6):378-82. PubMed ID: 11678459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis.
    Ghachem I; El Borgi W; Fekih Salem S; Ben Lakhal F; Chelbi A; Ghiriani I; Gouider E
    Ann Biol Clin (Paris); 2020 Apr; 78(2):206-209. PubMed ID: 32319951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of factor V inhibitor in a patient on amiodarone therapy.
    Shreenivas AV; Lipshitz J; Patel D
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):342-4. PubMed ID: 22473049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired factor V inhibitors: a systematic review.
    Franchini M; Lippi G
    J Thromb Thrombolysis; 2011 May; 31(4):449-57. PubMed ID: 21052780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired factor V inhibitors.
    Knöbl P; Lechner K
    Baillieres Clin Haematol; 1998 Jun; 11(2):305-18. PubMed ID: 10097809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Inhibitors: A Diagnostic and Therapeutic Challenge.
    Olson NJ; Ornstein DL
    Arch Pathol Lab Med; 2017 Dec; 141(12):1728-1731. PubMed ID: 29189062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A circulating factor V inhibitor: possible side effect of treatment with streptomycin.
    Stenbjerg S; Husted S; Mygind K
    Scand J Haematol; 1975 May; 14(4):280-5. PubMed ID: 1153957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation in a patient with an acquired high-titre factor V inhibitor.
    Schmidt DE; Steinhagen F; Schnabel C; Spath B; Holstein K; Fiedler W; Bokemeyer C; Renné T; Langer F
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):81-7. PubMed ID: 25158984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.